Technology
Health
Biotechnology
IsoRay
$0.39769876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.3976
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0126 (-3.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell IsoRay and other stocks, options, ETFs, and crypto commission-free!
About ISR
IsoRay, Inc., also called IsoRay, is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Read More Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.
Employees
38
Headquarters
Richland, Washington
Founded
1983
Market Cap
27.62M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
62.41K
High Today
$0.41
Low Today
$0.3685
Open Price
$0.4099
Volume
104.73K
52 Week High
$0.67
52 Week Low
$0.2691
Collections
Technology
Health
Biotechnology
Medical
Cancer Prevention
US
North America
Female CEOs
Price Paid on Robinhood
26% Lower
Right Now
52 Week Low
$0.2691
Average Price Paid
$0.5379
52 Week High
$0.67
ISR Earnings
-$0.04
-$0.03
-$0.03
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Sep 24, After Hours